» Articles » PMID: 35013985

COVID-19 and Chronic Kidney Disease: an Updated Overview of Reviews

Overview
Journal J Nephrol
Publisher Springer
Specialty Nephrology
Date 2022 Jan 11
PMID 35013985
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Coronavirus disease (COVID-19) has resulted in the death of more than 3.5 million people worldwide. While COVID-19 mostly affects the lungs, different comorbidities can have an impact on its outcomes. We performed an overview of reviews to assess the effect of Chronic Kidney Disease (CKD) on contracting COVID-19, hospitalization, mortality, and disease severity.

Methods: We searched published and preprint databases. We updated the reviews by searching for primary studies published after August 2020, and prioritized reviews that are most updated and of higher quality using the AMSTAR tool.

Results: We included 69 systematic reviews and 66 primary studies. Twenty-eight reviews reported on the prevalence of CKD among patients with COVID-19, which ranged from 0.4 to 49.0%. One systematic review showed an increased risk of hospitalization in patients with CKD and COVID-19 (RR = 1.63, 95% CI 1.03-2.58) (Moderate certainty). Primary studies also showed a statistically significant increase of hospitalization in such patients. Thirty-seven systematic reviews assessed mortality risk in patients with CKD and COVID-19. The pooled estimates from primary studies for mortality in patients with CKD and COVID-19 showed a HR of 1.48 (95% CI 1.33-1.65) (Moderate certainty), an OR of 1.77 (95% CI 1.54-2.02) (Moderate certainty) and a RR of 1.6 (95% CI 0.88-2.92) (Low certainty).

Conclusions: Our review highlights the impact of CKD on the poor outcomes of COVID-19, underscoring the importance of identifying strategies to prevent COVID-19 infection among patients with CKD.

Citing Articles

Marked Global Differences in Mortality in Male Patients with COVID-19: An Analysis of the CARDIO COVID 19-20 and WHF COVID-19 CVD Studies.

Gomez-Mesa J, Arango-Ibanez J, Perel P, Prabhakaran D, Leon-Giraldo H, Toro-Pedroza A Glob Heart. 2025; 20(1):21.

PMID: 40026348 PMC: 11869830. DOI: 10.5334/gh.1403.


Impact of Prior Chronic Kidney Disease and Newly Detected eGFR Impairment at Admission on Outcomes and Prognosis of Hospitalized COVID-19 Patients - A Single-Center Cohort Study.

Kania M, Terlecki M, Batko K, Rajzer M, Malecki M, Krzanowski M Int J Gen Med. 2025; 18:593-602.

PMID: 39931311 PMC: 11808791. DOI: 10.2147/IJGM.S480994.


Predictors of COVID-19 Readmission Among Patients Previously Hospitalized for SARS-CoV-2.

Colaneri M, Canuti M, Torrigiani G, DallOlio L, Bobbio C, Baldi S Infect Dis Ther. 2025; 14(2):447-461.

PMID: 39838255 PMC: 11829856. DOI: 10.1007/s40121-024-01107-w.


Comparative analysis of C-Reactive protein levels among Non-comorbid, Comorbid, and Multimorbid Hospitalized COVID-19 patients.

Shoukat M, Khan H, Nazish M, Rehman A, Raashid S, Ahmed S BMC Infect Dis. 2025; 25(1):59.

PMID: 39810122 PMC: 11730823. DOI: 10.1186/s12879-024-10314-2.


Treatment pattern and clinical outcomes of remdesivir in hospitalized COVID-19 patients with severe chronic kidney disease: a database analysis of acute care hospitals in Japan.

Yoshida M, Taguchi N, Piao Y, Gupta R, Berry M, Peters J Clin Exp Nephrol. 2024; .

PMID: 39739156 DOI: 10.1007/s10157-024-02609-0.


References
1.
Baradaran A, Ebrahimzadeh M, Baradaran A, Kachooei A . Prevalence of Comorbidities in COVID-19 Patients: A Systematic Review and Meta-Analysis. Arch Bone Jt Surg. 2020; 8(Suppl 1):247-255. PMC: 7296605. DOI: 10.22038/abjs.2020.47754.2346. View

2.
Degarege A, Naveed Z, Kabayundo J, Brett-Major D . Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis. Pathogens. 2022; 11(5). PMC: 9147100. DOI: 10.3390/pathogens11050563. View

3.
Santos M, Lucena E, Lima K, Brito A, Bay M, Bonfada D . Survival and predictors of deaths of patients hospitalised due to COVID-19 from a retrospective and multicentre cohort study in Brazil. Epidemiol Infect. 2020; 148:e198. PMC: 7487752. DOI: 10.1017/S0950268820002034. View

4.
Kunutsor S, Laukkanen J . Renal complications in COVID-19: a systematic review and meta-analysis. Ann Med. 2020; 52(7):345-353. PMC: 7877945. DOI: 10.1080/07853890.2020.1790643. View

5.
Lala A, Johnson K, Januzzi J, Russak A, Paranjpe I, Richter F . Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection. J Am Coll Cardiol. 2020; 76(5):533-546. PMC: 7279721. DOI: 10.1016/j.jacc.2020.06.007. View